Common Abnormalities During Sterility Test and Their Impact on Product Quality

By -

Sterility testing is one of the most critical quality control procedures in the pharmaceutical industry. It ensures that sterile products, such as injectables, ophthalmic preparations, and surgical implants, are free from viable microorganisms. However, during sterility testing, certain abnormalities or unexpected observations may occur — such as turbidity in media, microbial growth, leakage, or equipment malfunction. Understanding and investigating these abnormalities is essential to maintain product quality, ensure regulatory compliance, and protect patient safety.

What is Sterility Testing?

Sterility testing is a microbiological test performed to confirm the absence of viable microorganisms in products that are required to be sterile. It is conducted under aseptic conditions using validated methods described in:

  • USP <71> — Sterility Tests
  • European Pharmacopeia (Ph. Eur.) 2.6.1 — Sterility
  • Indian Pharmacopeia (IP) 3.2.1 — Sterility Test
  • WHO TRS 961 Annex 6 — Sterility Testing Guidelines

Why Abnormalities Occur During Sterility Testing

Even when conducted under strict aseptic conditions, abnormal observations can arise due to human error, environmental conditions, equipment malfunction, or procedural lapses. These abnormalities do not always indicate true product contamination, but they must be investigated scientifically.

Common Abnormalities Observed During Sterility Tests

1. Turbidity in Culture Media

Turbidity or cloudiness in Fluid Thioglycollate Medium (FTM) or Soybean-Casein Digest Medium (SCDM) indicates potential microbial growth. However, false turbidity may occur due to:

  • Presence of product residues or precipitates
  • Improper filtration of viscous products
  • Over-incubation or medium degradation

2. Positive Growth in One or More Containers

The most serious abnormality is visible microbial growth in one or more sterility test units. This may result from:

  • True contamination during manufacturing or filling
  • Environmental contamination during testing
  • Improper aseptic handling or faulty isolator performance

3. Media Leakage or Cracked Containers

If test containers leak or break during incubation, it can lead to false positive results due to environmental contamination. This issue usually indicates:

  • Poor container-closure integrity (CCI)
  • Mechanical damage during transfer or incubation
  • Improper sealing of ampoules or vials

4. Environmental Deviations During Test

Abnormal temperature, humidity, or differential pressure in the cleanroom or isolator can compromise the sterility test. Such deviations can:

  • Impact microbial control in the environment
  • Cause condensation or microbial ingress
  • Lead to invalid test results

5. Operator Technique Errors

Analyst-related abnormalities are among the most frequent issues during sterility testing, including:

  • Inadequate aseptic handling
  • Touching sterile materials with non-sterile gloves
  • Not following proper gowning procedures
  • Improper sample transfer or inoculation

6. Media Control Failure

Each sterility test must include negative controls (uninoculated media) to verify the absence of contamination. If control media shows growth, it indicates:

  • Test environment contamination
  • Media preparation or sterilization failure
  • Isolator integrity breach

How to Handle Abnormalities Observed During Sterility Test

Step 1: Documentation of Observation

All abnormalities must be recorded in the sterility test record immediately, with details such as:

  • Date, time, and description of observation
  • Media type and sample identification
  • Environmental conditions during observation
  • Operator name and test batch details

Step 2: Initial Investigation

The initial investigation includes reviewing:

  • Environmental monitoring results during the test
  • Integrity of growth media and test apparatus
  • Incubator temperature records
  • Control media observations

Step 3: Confirmatory Testing

If microbial growth is observed, the organism should be identified using:

  • Gram staining
  • Biochemical tests
  • MALDI-TOF or 16S rRNA sequencing (if available)

This helps in distinguishing true product contamination from laboratory contamination.

Step 4: Root Cause Analysis

A systematic root cause analysis should be conducted using tools like:

  • Fishbone Diagram (Ishikawa)
  • 5 Whys Analysis
  • Failure Mode and Effects Analysis (FMEA)

Step 5: Corrective and Preventive Actions (CAPA)

Based on investigation findings, implement CAPA measures such as:

  • Analyst retraining on aseptic techniques
  • Improved environmental monitoring
  • Equipment calibration and requalification
  • Revision of SOPs and procedural controls

Impact of Abnormalities on Product Quality

Sterility test abnormalities can directly affect product quality and patient safety. A confirmed contamination indicates a breach in aseptic processing and requires batch rejection. Even false positives, if not properly investigated, can:

  • Delay batch release and product supply
  • Damage company reputation
  • Raise regulatory non-compliance issues

Regulatory Expectations

Regulatory agencies like US FDA, EMA, and WHO expect that:

  • All sterility test abnormalities are documented and investigated scientifically.
  • Investigations are unbiased, thorough, and supported with data.
  • Any confirmed contamination is reported to QA and regulatory authorities if required.
  • Preventive actions are implemented to avoid recurrence.

Best Practices to Prevent Abnormalities

  • Regular operator qualification and media fill studies.
  • Routine cleaning and disinfection of sterility testing areas.
  • Validated sterilization and filtration processes.
  • Continuous environmental monitoring and trend analysis.
  • Strict adherence to aseptic gowning and personnel hygiene.

Conclusion

Abnormalities observed during sterility testing should never be ignored. Each event provides valuable insight into potential weaknesses in the aseptic testing process. By maintaining strict control, proper documentation, and thorough investigation, pharmaceutical manufacturers can ensure that sterile products consistently meet the highest standards of safety and efficacy.

💬 About the Author

Siva Sankar is a Pharmaceutical Microbiology Consultant and Auditor with extensive experience in sterility testing, validation, and GMP compliance. He provides consultancy, training, and documentation services for pharmaceutical microbiology and cleanroom practices.

📧 Contact: siva17092@gmail.com
📱 Mobile: 09505626106

Disclaimer: This article is for educational purposes and does not replace your laboratory’s SOPs or regulatory guidance. Always follow validated methods and manufacturer instructions.

Comments

Post a Comment

Popular posts from this blog

Non-Viable particle count (NVPC)

By -
Image
Particle mater in room air limits are in particles of 0.5 μm and larger per cubic meter. ISO = cubic meter (m 3 ) FD Standard 209 E = cubic feet (ft 3 )   ISO class equal to federal standard 209 E class .  1m 3  = 35.31 ft 3 1m = 100 cm Adapted from former Federal Standard No. 209 E,                ISO = international organization for standard 14644 part -1, may -1999 p ublished. Maximum concentration limits (particles M3 of air) for particles equal to and larger than the considered sizes shown below: (a) ISO Classification Number(N) 0.1µm 0.2µm 0.3µm 0.5µm 1.0µm 5.0µm ISO 1 b                    10 d                 2 d d d e ISO 2 10...
Read more

Alert and Action Limits

By -
In pharmaceuticals alert and action limits are very important, because these limits are effective control to the process. alert and action limits are in house limits, these limits must be less than guideline limits or define limits. Alert and action limits defined based on trend analysis. alert and action limits are like a barrier before the guideline limits. Alert Limit: To be alert the microbial counts reach to this alert level. It is nor necessary to take any action. Possible deviation from normal process condition This is a trigger, that something is going wrong means microbial count increasing that area. Action Limits: When microbial count reach this action limits then action is mandatory. To control the  microbial count in the area. Signal an apparent deviation from normal process condition And require immediate action. If not controlled, we might get area failure. These alert and action limits must be less than final limits. Example : A...
Read more

TNTC vs TFTC

By -
Image
Too Numerous To Count (TNTC) or Too Many To Counts (TMTC) In samples with very high bacterial concentration, that is not suitable for counting (unable to get accurate counts) and reports the results as "to numerous to count" (TNTC). While the best solution is to collect another sample and dilute to get a more accurate counts, this might not always to be possible. Ideally one plate with 200 to 250 colonies are used. Counts above 250 are considered "to numerous to count" (TNTC), because it is impossible to count the colonies. plates countable range 25 to 250. Too Few To Count (TFTC): If there are less than 30 colonies on the plate, small errors in dilution technique or the presence of a few contaminants will have a drastic effect on the final count this count is called too few to count (TFTC).
Read more